TPCW
GMAB icon

TD Private Client Wealth’s Genmab GMAB Stock Holding History

TD Private Client Wealth’s Portfolio GMAB Stock Details GMAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$140K Sell
5,200
-3,160
-38% -$94.7K ﹤0.01% 713
2025
Q4 		$257K Buy
8,360
+893
+12% +$27.8K 0.01% 610
2025
Q3 		$229K Buy
7,467
+1,159
+18% +$28.2K 0.01% 634
2025
Q2 		$130K Sell
6,308
-1,759
-22% -$36.1K ﹤0.01% 707
2025
Q1 		$158K Sell
8,067
-3,481
-30% -$73K ﹤0.01% 647
2024
Q4 		$241K Sell
11,548
-268
-2% -$5.89K 0.01% 565
2024
Q3 		$288K Sell
11,816
-2,038
-15% -$54.5K 0.01% 539
2024
Q2 		$348K Buy
13,854
+71
+0.5% +$2.01K 0.01% 490
2024
Q1 		$412K Buy
13,783
+1,100
+9% +$32.3K 0.01% 473
2023
Q4 		$404K Buy
12,683
+7,737
+156% +$243K 0.01% 464
2023
Q3 		$174K Buy
4,946
+2,718
+122% +$104K 0.01% 570
2023
Q2 		$84.7K Buy
2,228
+360
+19% +$14.4K ﹤0.01% 689
2023
Q1 		$70.5K Sell
1,868
-3,728
-67% -$143K ﹤0.01% 702
2022
Q4 		$237K Buy
5,596
+321
+6% +$13.2K 0.01% 524
2022
Q3 		$169K Buy
5,275
+4,173
+379% +$147K 0.01% 550
2022
Q2 		$35.8K Sell
1,102
-3,090
-74% -$100K ﹤0.01% 798
2022
Q1 		$152K Buy
4,192
+1,141
+37% +$39.2K 0.01% 581
2021
Q4 		$121K Buy
3,051
+853
+39% +$35.6K 0.01% 612
2021
Q3 		$96.1K Buy
2,198
+134
+6% +$6.02K ﹤0.01% 634
2021
Q2 		$84.3K Buy
2,064
+1,438
+230% +$55.5K ﹤0.01% 639
2021
Q1 		$20.6K Buy
626
+17
+3% +$639 ﹤0.01% 823
2020
Q4 		$24.8K Sell
609
-361
-37% -$13.5K ﹤0.01% 754
2020
Q3 		$35.5K Buy
970
+957
+7,362% +$34.6K ﹤0.01% 659
2020
Q2 		$441 Sell
13
-3,063
-100% -$83.5K ﹤0.01% 1038
2020
Q1 		$65.2K Buy
3,076
+412
+15% +$9.18K ﹤0.01% 546
2019
Q4 		$59.5K Buy
+2,664
New +$58.1K ﹤0.01% 583

Other funds holding GMAB

OAG
Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
HL
Harding Loevner Bridgewater, New Jersey $9.72B AUM 22.38% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

TD Private Client Wealth's GMAB Position: Q1 2026 in Review

TD Private Client Wealth reduced its Genmab (GMAB) stake by 38% in Q1 2026, selling an estimated $94.7K and leaving 5,200 shares worth $140K. The position accounts for ﹤0.01% of the portfolio, ranked #713.

TD Private Client Wealth first reported a position in GMAB in Q4 2019 and has held it in 26 quarters since. The position peaked at $412K in Q1 2024. 272 funds tracked by Wall St. Rank hold GMAB as of Q1 2026.

  • TD Private Client Wealth held 5,200 shares of Genmab worth $140K as of Q1 2026.
  • TD Private Client Wealth sold 3,160 Genmab shares in Q1 2026, an estimated $94.7K.
  • Genmab made up ﹤0.01% of TD Private Client Wealth's portfolio in Q1 2026, its #713 holding.
  • TD Private Client Wealth first reported a position in Genmab in Q4 2019 and has held it in 26 quarters since.
  • TD Private Client Wealth's Genmab position peaked at $412K in Q1 2024.
  • 272 funds tracked by Wall St. Rank held Genmab as of Q1 2026.

Based on TD Private Client Wealth's 13F filing for Q1 2026, filed 27 Apr 2026.